RB1 and urinary bladder cancer: Choi once reported that bladder cancer with mutation of RB1 and NFE2L2 can be enriched into basal subtype of muscle-invasive bladder cancer (Choi et al., 2017), which could be divided into epithelial–basal and more clinically aggressive mesenchymal subtypes (Guo et al., 2019).